Symbol
| VSIG4
| contributors: mct - updated : 21-12-2017
|
HGNC name
| V-set and immunoglobulin domain containing 4
|
HGNC id
| 17032
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
| --over
|  
|
in ovarian cancers compared with that in benign tumors | |
Variant & Polymorphism
|
| |
Candidate gene
Marker
| VSIG4 expression in Multiple myeloma (MM) is an independent indicator of poor prognosis, implying a possible therapeutic target for immunotherapy for MM | |
soluble VSIG4 may be used as a potential biomarker for predicting ovary tumor prognosis | Therapy target
|
System | Type | Disorder | Pubmed |
cancer | reproductive | ovary | |
potential therapeutic target for ovarian cancer |
| | |